A detailed history of Canandaigua National Bank & Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Canandaigua National Bank & Trust CO holds 31,135 shares of ABBV stock, worth $5.18 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
31,135
Previous 32,124 3.08%
Holding current value
$5.18 Million
Previous $4.98 Million 13.88%
% of portfolio
0.9%
Previous 0.83%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 01, 2024

SELL
$159.82 - $182.1 $158,061 - $180,096
-989 Reduced 3.08%
31,135 $5.67 Million
Q4 2023

Jan 04, 2024

SELL
$137.6 - $154.97 $221,260 - $249,191
-1,608 Reduced 4.77%
32,124 $4.98 Million
Q3 2023

Oct 10, 2023

BUY
$133.59 - $154.65 $760,928 - $880,886
5,696 Added 20.32%
33,732 $5.03 Million
Q2 2023

Jul 03, 2023

SELL
$132.51 - $164.9 $58,569 - $72,885
-442 Reduced 1.55%
28,036 $3.78 Million
Q1 2023

Apr 11, 2023

SELL
$144.61 - $166.54 $483,865 - $557,242
-3,346 Reduced 10.51%
28,478 $4.54 Million
Q1 2020

Apr 16, 2020

SELL
$64.5 - $97.79 $17,350 - $26,305
-269 Reduced 0.84%
31,824 $2.43 Million
Q4 2019

Jan 17, 2020

SELL
$72.13 - $90.25 $71,480 - $89,437
-991 Reduced 3.0%
32,093 $2.84 Million
Q3 2019

Nov 13, 2019

BUY
$62.98 - $75.72 $119,662 - $143,868
1,900 Added 6.09%
33,084 $2.51 Million
Q2 2019

Jul 19, 2019

BUY
$65.7 - $83.98 $16,096 - $20,575
245 Added 0.79%
31,184 $2.27 Million
Q1 2019

Apr 25, 2019

SELL
$77.14 - $90.79 $625,219 - $735,852
-8,105 Reduced 20.76%
30,939 $2.49 Million
Q4 2018

Feb 06, 2019

SELL
$77.85 - $96.01 $63,836 - $78,728
-820 Reduced 2.06%
39,044 $3.6 Million
Q3 2018

Nov 02, 2018

BUY
$88.91 - $98.84 $148,746 - $165,359
1,673 Added 4.38%
39,864 $3.77 Million
Q2 2018

Aug 03, 2018

BUY
$89.78 - $106.23 $200,927 - $237,742
2,238 Added 6.22%
38,191 $3.54 Million
Q1 2018

May 09, 2018

BUY
$92.01 - $123.21 $3.31 Million - $4.43 Million
35,953 New
35,953 $3.4 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $294B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Canandaigua National Bank & Trust CO Portfolio

Follow Canandaigua National Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canandaigua National Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Canandaigua National Bank & Trust CO with notifications on news.